Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 179 Urinary Bladder Neoplasms 31 Carcinoma, Renal Cell 19 Kidney Neoplasms 18 Breast Neoplasms 13 Wilms Tumor 11 Neoplasms 10 Neoplasm Metastasis 10 Lung Neoplasms 9 Testicular Neoplasms 8 Testicular Germ Cell Tumor 6 Melanoma 6 Carcinoma, Non-Small-Cell Lung 6 Non-Muscle Invasive Bladder Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Endometrial Neoplasms 5 Dendritic Cell Sarcoma, Interdigitating 5 Burkitt Lymphoma 5 Vaginal Neoplasms 4 Uterine Cervical Neoplasms 4 Urethral Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Seminoma 4 Sarcoma 4 Recurrence 4 Rectal Neoplasms 4 Radiation Injuries 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4

Interventions

Gemcitabine 4 Cisplatin 4 pembrolizumab 3 Carboplatin 3 erdafitinib 2 durvalumab 2 vinflunine 1 tremelimumab 1 niraparib 1 enfortumab vedotin 1 cabozantinib 1 avelumab 1 atezolizumab 1 Tiragolumab 1 Sunitinib 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Nivolumab 1 Midazolam 1 Metformin 1 Ipilimumab 1 Everolimus 1 Docetaxel 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urothelial Cancer × Radiotherapy × Genitourinary × Clear all

NCT02891161 2024-11-27

DUART

Big Ten Cancer Research Consortium

Phase 1/2 Terminated

26 enrolled 20 charts

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡